Current advances in Hodgkin’s lymphoma

Hodgkin’s lymphoma is a highly treatable malignancy. It has high cure rates yet there are many patients who relapse or are refractory to treatment. Traditionally, treatment has been with conventional chemotherapy; however, the development of brentuximab vedotin and immune checkpoint inhibitors has r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Joseph Vadakara, Benjamin Andrick
Formato: article
Lenguaje:EN
Publicado: KeAi Communications Co., Ltd. 2019
Materias:
Acceso en línea:https://doaj.org/article/581c062dee694a08ac01bdf0eca28236
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!